F/M Emerald Life Sciences Innovation ETF (LFSC)

Assets	$99.94M
Expense Ratio	0.54%
PE Ratio	n/a
Shares Out	2.67M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	1,040
Open	37.12
Previous Close	37.27
Day's Range	37.12 - 37.49
52-Week Low	22.19
52-Week High	40.10
Beta	n/a
Holdings	44
Inception Date	Oct 31, 2024

About LFSC

Fund Home Page

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: LFSC
• ETF Provider: F/m Investments

Top 10 Holdings

54.64% of assets

Name	Symbol	Weight
Cogent Biosciences, Inc.	COGT	8.21%
Travere Therapeutics, Inc.	TVTX	7.00%
LivaNova PLC	LIVN	6.62%
Spyre Therapeutics, Inc.	SYRE	6.37%
Mirum Pharmaceuticals, Inc.	MIRM	4.70%
Nektar Therapeutics	NKTR	4.66%
United Therapeutics Corporation	UTHR	4.51%
KalVista Pharmaceuticals, Inc.	KALV	4.35%
US DOLLARS	n/a	4.21%
TransMedics Group, Inc.	TMDX	4.00%

Performance

LFSC had a total return of 70.83% in the past year, including dividends. Since the fund's inception, the average annual return has been 31.46%.